Cat Allergy in Humans Market: By Product Type (Symptom Relief Drug and Allergen Blocker, Air Purifier, Allergen Immunotherapy, Others), By Application (Allergy Treatment, Allergy Prevention), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Cat Allergy In Humans Market size was valued at USD 4,682.1 million in 2022 and is anticipated to grow at a CAGR of 7.8% over 2023-2029. Cat allergies in humans are caused by proteins found in a cat's skin cells, urine, and saliva. When these proteins are released into the air and come into contact with a person who is sensitive or allergic to them, they can trigger an allergic reaction. Symptoms of cat allergies can include sneezing, runny or stuffy nose, itchy or watery eyes, coughing, wheezing, and skin rashes. The increasing trend of pet ownership plays a pivotal role in driving the revenues of cat allergy in humans market. As more individuals welcome cats into their households, the potential customer base for products and services geared toward managing cat allergies expands significantly. This rise in pet ownership leads to a higher likelihood of people encountering cat allergens, whether they own cats themselves or not. Consequently, there is a growing awareness of cat allergies, prompting more individuals to seek diagnosis and treatment. This surge in demand for solutions to manage cat allergies fuels innovation in the development of various products, ranging from medications and hypoallergenic pet supplies to air purifiers and allergen-reducing cleaning solutions.

Moreover, the escalation of awareness about cat allergies and the importance of diagnosis significantly propels the growth of cat allergy in humans market. As public knowledge about allergies expands, more individuals become cognizant of the various symptoms and triggers associated with cat allergies. This heightened awareness prompts those experiencing allergic reactions to seek medical attention and proper diagnosis. As a result, the market experiences an uptick in demand for allergy testing, consultations with allergists, and related medical services. However, limited treatment options and incomplete allergen elimination from indoor environments can hinder the growth of cat allergy in humans market. Meanwhile, ongoing research and development of more effective allergy medications, immunotherapies, and other treatments can contribute to a growing market as people seek better solutions for managing their allergies. Key manufacturers are innovating excellent solutions to cater to the end-users. For example, in February 2020, Nestlé Purina developed the first and only nutritious and balanced dry cat food that reduces the allergens in cat hair and dander.

Cat Allergy in Humans Market Key Developments:   
  • In February 2021, Regeneron Pharmaceuticals, Inc. released detailed findings from a Phase 2 proof-of-concept study that tested the investigational antibody cocktail REGN1908-1909 in patients with mild asthma who are allergic to cats.

Cat Allergy In Humans Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.8%

Largest Market

North America

Fastest Growing Market

North America
Cat Allergy in Humans Market Dynamics

With raising urbanization pet adoption is also increasing. Keeping cats as pet animal is very common nowadays. Cats require less training, handle relatively long periods of alone time, cost relatively less in veterinary and day-to-day care, self-reliant and loving. They are even in homes and other places that have never housed pets. Due the increasing demands for cat as a pet animal the prevalence of occurring allergy in humans due to cats is also increasing. This in turn is leading to the growth of global market.

Cat Allergy In Humans Market Segmentation

By Product Type
  • Symptom Relief Drug and Allergen Blocker
  • Air Purifier
  • Allergen Immunotherapy
  • Others
By Application
  • Allergy Treatment
  • Allergy Prevention

Frequently Asked Questions

Urbanization and indoor lifestyles, and Consumer demand for non-invasive solutions are some of the key opportunities for companies to enhance their revenue over the forecast years.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

Advancements in air purification technologies and home cleaning products that specifically target allergens and personalized medicine and treatments tailored to an individual's specific allergies stand out as a significant trend within the cat allergy in human market.

Key Features of the Reports

  • The cat allergy in humans market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1.Executive Summary
2.Global Cat Allergy in Humans Market Introduction 
2.1.Global Cat Allergy in Humans Market  - Taxonomy
2.2.Global Cat Allergy in Humans Market  - Definitions
2.2.1.Product Type 
2.2.2.Application
2.2.3.Region
3.Global Cat Allergy in Humans Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Cat Allergy in Humans Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Cat Allergy in Humans Market  By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Symptom Relief Drug and Allergen Blocker
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Air Purifier
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Allergen Immunotherapy
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Cat Allergy in Humans Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Allergy Treatment
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Allergy Prevention
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Cat Allergy in Humans Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Cat Allergy in Humans Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Product Type  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Symptom Relief Drug and Allergen Blocker
8.1.2.Air Purifier
8.1.3.Allergen Immunotherapy
8.1.4.Others
8.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Allergy Treatment
8.2.2.Allergy Prevention
8.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Cat Allergy in Humans Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Symptom Relief Drug and Allergen Blocker
9.1.2.Air Purifier
9.1.3.Allergen Immunotherapy
9.1.4.Others
9.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Allergy Treatment
9.2.2.Allergy Prevention
9.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
 
10.Asia Pacific (APAC) Cat Allergy in Humans Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Symptom Relief Drug and Allergen Blocker
10.1.2.Air Purifier
10.1.3.Allergen Immunotherapy
10.1.4.Others
10.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Allergy Treatment
10.2.2.Allergy Prevention
10.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Cat Allergy in Humans Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Symptom Relief Drug and Allergen Blocker
11.1.2.Air Purifier
11.1.3.Allergen Immunotherapy
11.1.4.Others
11.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Allergy Treatment
11.2.2.Allergy Prevention
11.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Cat Allergy in Humans Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Symptom Relief Drug and Allergen Blocker
12.1.2.Air Purifier
12.1.3.Allergen Immunotherapy
12.1.4.Others
12.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Allergy Treatment
12.2.2.Allergy Prevention
12.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Alen (USA)
13.2.2.Rabbit Air (USA)
13.2.3.Honeywell (USA)
13.2.4.SC Johnson (Wisconsin)
13.2.5.Stallergenes Greer (UK)
13.2.6.Hindustan Antibiotic Limited (India)
13.2.7.Jubilant HollisterStier Allergy (Washington)
13.2.8.Blueair AB (Sweden)
13.2.9.Winix (South Korea)
13.2.10.SANOFI (France)
13.2.11.Bayer (Germany)
13.2.12.Glaxo SmithKline (UK)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Alen (USA)
  • Rabbit Air (USA)
  • Honeywell (USA)
  • SC Johnson (Wisconsin)
  • Stallergenes Greer (UK)
  • Hindustan Antibiotic Limited (India)
  • Jubilant HollisterStier Allergy (Washington)
  • Blueair AB (Sweden)
  • Winix (South Korea)
  • SANOFI (France)
  • Bayer (Germany)
  • Glaxo SmithKline (UK)
  • Johnson & Johnson Consumer Inc. (Pennsylvania)
  • Pfizer Inc. (New York)

Adjacent Markets